Evolving preferences of HCPs during the pandemic have put an emphasis on learning new skillsets for pharma reps.
Jim Whitaker
Advertisement
Articles by Jim Whitaker
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
2
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
3
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
4
Beyond the Trial: How Integrating RWE and PROs is Redefining Treatment Success
5
